Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
arcticnovartis
- Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing a 3.0% yield¹
- Shareholders confirm Giovanni Caforio as Chair of the Board of Directors as well as all other members of the Board of Directors who stood for re-election; Charles Swanton newly elected as member of the Board of Directors